OpenCapital
Beta
Calendar
Stocks
Metrics
Connect AI
/
Stocks
Portfolio
Sign In
Toggle navigation menu
Stocks
Natera, Inc.
Balance Sheet Statement
Clinical samples payable
Other
Clinical samples payable
Export Chart
Analysis
Statement
Balance Sheet Statement
Section
Other
First reported
Q1 2026
Last reported
Q1 2026
Metric ID:
other_clinical_samples_payable
Historical Data
1 periods
Quarterly
Q1 '26
Value
$3.70M
Frequently Asked Questions
What is Natera, Inc.'s clinical samples payable?
Natera, Inc. (NTRA) reported clinical samples payable of $3.70M in Q1 2026.